Initial Observations on the Effects of Δ9‐Tetrahydrocannabinol on the Plasma Pharmacokinetics of Cyclophosphamide and Doxorubicin

CHARLES E. RIGGS, MERRILL J. EGORIN, JOACHIM Z. FUKS, NATHAN SCHNAPER, PATRICIA DUFFEY, O. MICHAEL COLVIN, JOSEPH AISNER, PETER H. WIERNIK, NICHOLAS R. BACHUR

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Abstract: We studied the effect of THC upon the pharmacokinetics of cyclophosphamide (CTX) and doxorubicin (ADR). Plasma THC was determined by RIA. Plasma concentrations of CTX and ADR were measured by GLC and fluorescence, respectively. RIA confirmed plasma levels of THC >20 ng/ml for patients who received THC. CTX half‐life was not significantly changed with use of THC (7.7 ± 3.6 hours without versus 5.25 ± 2.6 hours with THC). ADR half‐life with THC was greater than without THC (175 ± 197 hours versus 92 ± 92 hours, respectively). Total drug exposure as determined by areas under the curves were similar (12.4 ± 6 μM · hr without versus 13.8 ± 4 μM · hr with THC). These preliminary data suggest that RIA is reliable for assessing THC plasma concentrations. THC induces no apparent alterations of CTX or ADR pharmacokinetics. 1981 American College of Clinical Pharmacology

Original languageEnglish (US)
Pages (from-to)90S-98S
JournalThe Journal of Clinical Pharmacology
Volume21
Issue number1 S
DOIs
StatePublished - Jan 1 1981
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Initial Observations on the Effects of Δ<sup>9</sup>‐Tetrahydrocannabinol on the Plasma Pharmacokinetics of Cyclophosphamide and Doxorubicin'. Together they form a unique fingerprint.

  • Cite this

    RIGGS, CHARLES. E., EGORIN, MERRILL. J., FUKS, JOACHIM. Z., SCHNAPER, NATHAN., DUFFEY, PATRICIA., COLVIN, O. MICHAEL., AISNER, JOSEPH., WIERNIK, PETER. H., & BACHUR, NICHOLAS. R. (1981). Initial Observations on the Effects of Δ9‐Tetrahydrocannabinol on the Plasma Pharmacokinetics of Cyclophosphamide and Doxorubicin. The Journal of Clinical Pharmacology, 21(1 S), 90S-98S. https://doi.org/10.1002/j.1552-4604.1981.tb02581.x